Infliximab is effective in the treatment of ulcerative colitis with dermatomyositis: A case report

doi:10.3748/wjg.v26.i46.7425

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 46

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6181)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-9) series.

Item

Count

PDF

413

WORD

211

HTML

3213

Figures (1-9)

266

Sum=4103

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

704

Download

1374

Sum=2078

Dec 14, 2020 (publication date) through Nov 11, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Dec 14, 2020; 26(46): 7425-7435
Published online Dec 14, 2020. doi: 10.3748/wjg.v26.i46.7425

Full Size Figure Download Figure

Figure 9 Colonoscopy re-examination after the fourth infliximab treatment.

Citation: Huang BB, Han LC, Liu GF, Lv XD, Gu GL, Li SQ, Chen L, Wang HQ, Zhan LL, Lv XP. Infliximab is effective in the treatment of ulcerative colitis with dermatomyositis: A case report. World J Gastroenterol 2020; 26(46): 7425-7435
URL: https://www.wjgnet.com/1007-9327/full/v26/i46/7425.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i46.7425